Knowing that direct inhibition of the drug efflux function of ABC transporters remains the most effective approach to resensitize multidrug-resistant cancer cells to chemotherapeutic drugs, tremendous efforts have been invested into developing novel synthetic inhibitors of ABCB1 and ABCG2 [19,50]. Here, ABCB1 is linked to cancer.